ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Flu H5 egg pandemic low dose vaccine, with adjuvant

Also written as “Flu H5 Egg Pandemic medium dose vaccine, with adjuvant”, “Flu H5 Egg Pandemic high dose vaccine, with adjuvant” and “Flu H5 Egg Pandemic high dose vaccine, without adjuvant”.

Its studies are mostly in Influenza, Human, led by Sanofi.

Furthest: phase 2, since Jul 31, 20261 company-led study, 1 open or runningNext primary completion: Feb 22, 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofi11 open or runningphase 2since Jul 31, 2026Jul 31, 2026Feb 22, 2028phase 2 · NCT07779408

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 31, 2026First study: phase 2 study in Influenza, HumanFirst studyNCT07779408 · 640 planned · United States

Ahead

  1. Feb 22, 2028Primary completion: phase 2 study in Influenza, HumanNCT07779408

TargetBeta

A vaccine: it acts on a pathogen, not a human gene.

“Flu H5 egg pandemic low dose vaccine, with adjuvant”name, by rule

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07779408Influenza, Human · United States2RecruitingFeb 22, 2028640

How it is read

Names in the registry

  • “Flu H5 egg pandemic low dose vaccine, with adjuvant”, 1 entry
  • “Flu H5 Egg Pandemic medium dose vaccine, with adjuvant”, 1 entry
  • “Flu H5 Egg Pandemic high dose vaccine, with adjuvant”, 1 entry
  • “Flu H5 Egg Pandemic high dose vaccine, without adjuvant”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.